← Back to Dashboard

Fluoxetine

Selective serotonin reuptake inhibitor

2D Structure

Could not render structureView on PubChem

3D Structure

No structure available on PubChemSearch PubChem

Chemical Identifiers

CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F
RTHCYVBBDHJXIQ-UHFFFAOYSA-N
ClinicalTrials.govPubMed

Clinical Development by Virus9

Severe acute respiratory syndrome-related coronavirus
SARS-CoV-2
Target: Viral ATPase/helicase
Phase 2
Preclinical
Phase 2negative
Phase 3
Approved
Phase 2 ref (PMID:39896880) PMID:33723270 NCT04377308
Dengue virus
DENV-2
Target: Viral ATPase/helicase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:27572397
Hepacivirus C
HCV
Target: Viral ATPase/helicase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:25151487
Enterovirus B
CVB-3
Target: Viral ATPase/helicase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:23335743
Enterovirus B
ECHOV-1
Target: Viral ATPase/helicase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:23335743
Enterovirus B
ECHOV-11
Target: Viral ATPase/helicase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:23335743
Enterovirus B
ECHOV-9
Target: Viral ATPase/helicase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:23335743
Enterovirus D
EV-D68
Target: Viral ATPase/helicase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:23335743
Enterovirus D
EV-D70
Target: Viral ATPase/helicase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:23335743